2012
DOI: 10.1016/j.jconrel.2011.11.027
|View full text |Cite
|
Sign up to set email alerts
|

Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: Analysis of drug and water diffusion processes with X-ray-based methods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 29 publications
0
18
0
Order By: Relevance
“…In this case, the methylcellulose dissolves out of the film leaving small channels in the film through which drug can diffuse. The ethyl cellulose barrier left on the particle serves as restraining barrier to maintain constant diffusion area and constant diffusion path length [29][30][31][32].…”
Section: Models Based On Diffusionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this case, the methylcellulose dissolves out of the film leaving small channels in the film through which drug can diffuse. The ethyl cellulose barrier left on the particle serves as restraining barrier to maintain constant diffusion area and constant diffusion path length [29][30][31][32].…”
Section: Models Based On Diffusionmentioning
confidence: 99%
“…With coated products, one can obtain pulsed dosing effects i.e., repeat action, by merely employing a small number of different thickness coated particles, or obtaining the more common sustained effect by utilizing a spectrum of different thickness coatings. Some granules within each group release the drug at intervals overlapping other groups, resulting in a smooth rather than discontinuous release, profile [29][30][31][32].…”
Section: Models Based On Dissolutionmentioning
confidence: 99%
“…These droplets are subsequently cooled down by falling through a tempered cooling tower and gathered as spheres with narrow size distribution. Main drawback of HME and prilling is the requirement of higher processing temperatures, which are in general not suitable for thermo-labile compounds [Ceowley et al, 2007;Lang et al, 2014;Maniruzzaman et al, 2012;Pivette et al, 2012;Repka et al, 2007;Repka et al, 2012;Sequier et 4 al., 2014;Vervaeck et al, 2013]. Pharmaceutically approved lipids are excipients suitable for production of solid oral dosage forms by melting technologies, due to their biocompatibility, lowtoxicity, compatibility with many active compounds, moderate melting temperatures and low cost.…”
Section: Introductionmentioning
confidence: 99%
“…As lipid-based formulations can be processed using different techniques (direct compression, melt granulation, melt extrusion, molding, spray congealing/prilling, solid lipid extrusion, hot-melt coating), this paper evaluates the impact of 2 continuous processing techniques (prilling and solid lipid extrusion) on the characteristics of multiparticulate fatty acid-based formulations. In contrast to prilling where the entire lipid fraction must be molten to obtain a liquid with adequate viscosity for pumping through a calibrated nozzle to create droplets [8,9], solid lipid extrusion (SLE) operates below the melting point of the lipid component. Via a thermo-mechanical treatment at moderate pressure and temperature, the mass is sufficiently plasticized to mold it through the die of the extruder [1].…”
Section: Introductionmentioning
confidence: 99%